Legal Representation
Attorney
Alexandre Montagu
USPTO Deadlines
Next Deadline
1884 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-09-17)
Due Date
September 17, 2030
Grace Period Ends
March 17, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 17, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Sep 17, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 13, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Aug 13, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jun 29, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 29, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| May 22, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| May 22, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 22, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| May 21, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 21, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 21, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 21, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 26, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 26, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 6, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 21, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 21, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 28, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 11, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical research and development in the field of drug target discovery
First Use Anywhere:
20230200
First Use in Commerce:
20230200
Classification
International Classes
042